Glenmark introducing Remogliflozin + Vildagliptin combination first time in India
Glenmark Pharmaceuticals Limited is introducing a fixed dose combination (FDC) of Remogliflozin + Vildagliptin. Remogliflozin is Sodium Glucose Co-Transporter Inhibitor (SGLT2i). Sodium/glucose... Read More
Pfizer submitted application for emergency use of Covid vaccine
US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government... Read More
Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China
Posted on20 Nov 2020
Comments0
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Fresenius Kabi announced an agreement to develop, register and distribute Veltassa for the treatment... Read More
Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning
Posted on30 Oct 2020
Tagsgilead, Gilead Sciences, pharma strategic deal, Remdesivir, Strategic deal in pharma, strategic management in pharma, Veklury
Comments0
FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients 12 years of age... Read More
Centaur Pharma launches WOXheal to treat diabetic foot ulcers
Centaur Pharmaceuticals announced the launch of a new chemical entity (NCE) – WOXheal for the treatment of diabetic foot ulcers, and it... Read More
Insight on First approved COVID-19 vaccine Sputnik V
Posted on11 Aug 2020
Comments0
Russia has announced the launch of first approved covid-19 vaccine. The Covid-19 vaccine brand name is Sputnik V. Sputnik V is developed... Read More
Florio GmbH introducing new digital platform aiming to improve the lives of people with haemophilia
Swedish Orphan Biovitrum AB (publ) (Sobi) has announced the launch by its affiliate, Florio GmbH, of Florio, a digital medical device designed... Read More
Cipla launches GLYCOHALEÂ respule
Cipla has annouced the introduction of Glycohale Respules. This helps Cipla to strengthen the Respiratory portfolio. Glycopyrrolate inhalation is indicated for the... Read More
Case Study : Rx-to-OTC switch of Voltaren arthritis pain
In this article we will be understanding about the Rx-to-OTC switch of Voltaren arthritis pain. It is one of the drug which... Read More
Pharma brand acquisition case study: Amgen to acquire Celgene’s Otezla
Amgen announced today that it has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers... Read More